Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 7/20 | 0.32 |
| ▸ | BCHE | P06276 | 7/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL40912 | 0.95 | BCHE (0.33) | BCHEACHETP53TSHR | |
| Bromide SCHEMBL1054366 | 0.90 | BCHE (0.37) | BCHEACHETP53TSHR | |
| Bromide SCHEMBL3113417 | 0.90 | BCHE (0.32) | BCHEACHETP53TSHR | |
| SCHEMBL4277059 | 0.90 | BCHE (0.32) | BCHEACHETP53TSHR | |
| Hydrochloric Acid SCHEMBL3377721 | 0.90 | BCHE (0.32) | BCHEACHETP53TSHR | |
| SCHEMBL7907973 | 0.90 | BCHE (0.32) | BCHEACHETP53TSHR | |
| SCHEMBL6559587 | 0.90 | BCHE (0.32) | BCHEACHETP53TSHR | |
| Ammonia Solution, Strong SCHEMBL11318386 | 0.90 | BCHE (0.32) | BCHEACHETP53TSHR | |
| SCHEMBL3497535 | 0.90 | BCHE (0.32) | BCHEACHETP53TSHR | |
| Water SCHEMBL3117304 | 0.86 | HSPD1 (0.32) | BCHEACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4553061-A1 | METHOD FOR PRODUCING FLUORINATED ORGANIC COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2025-05-14 | — | — | EP | disclosed |
| CN-119403778-A | Process for producing fluorinated organic compound | 大金工业株式会社 | 2025-02-07 | — | — | CN | disclosed |
| WO-2024009998-A1 | METHOD FOR PRODUCING FLUORINATED ORGANIC COMPOUND | ダイキン工業株式会社 | 2024-01-11 | — | — | WO | disclosed |
| CN-112020485-B | Process for producing difluoromethylene compound | 大金工业株式会社 | 2023-11-14 | — | — | CN | disclosed |
| EP-4223736-A1 | PRODUCTION METHOD FOR FLUORINATED ORGANIC COMPOUND | Daikin Industries, Ltd. (JP) | 2023-08-09 | — | — | EP | disclosed |
| US-20230242468-A1 | PRODUCTION METHOD FOR FLUORINATED ORGANIC COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2023-08-03 | — | — | US | disclosed |
| CN-116249686-A | Process for producing fluorinated organic compound | 大金工业株式会社 | 2023-06-09 | — | — | CN | disclosed |
| CN-109206570-B | Flexible physical split-phase supermolecular dynamic polymer and application thereof | 厦门天策材料科技有限公司 | 2023-04-25 | — | — | CN | disclosed |
| US-11377407-B2 | Method for producing difluoromethylene compound | DAIKIN INDUSTRIES, LTD. (JP) | 2022-07-05 | — | — | US | disclosed |
| WO-2022071363-A1 | PRODUCTION METHOD FOR FLUORINATED ORGANIC COMPOUND | ダイキン工業株式会社 | 2022-04-07 | — | — | WO | disclosed |
| EP-2966684-A1 | ELECTRONIC ELEMENT | Japan Science and Technology Agency (JP) | 2016-01-13 | — | — | EP | disclosed |
| US-7311890-B2 | Process for the production of fluorinated organic compounds and fluorinating agents | DAIKIN INDUSTRIES, LTD. (JP) | 2007-12-25 | — | — | US | disclosed |
| US-20040245505-A1 | Process for the production of fluorinated organic compounds and fluorinating agents | DAIKIN INDUSTRIES, LTD. (JP) | 2004-12-09 | — | — | US | disclosed |
| US-6784327-B2 | ORGANIC COMPOUNDS HAVING HYDROGEN ATOMS, WHICH SERVE AS STARTING MATERIALS, ARE FLUORINATED USING IF5 | DAIKIN INDUSTRIES, LTD. (JP) | 2004-08-31 | — | — | US | disclosed |
| US-20030176747-A1 | Process for the production of fluorinated organic compounds and fluorinating agents | DAIKIN INDUSTRIES, LTD. (JP) | 2003-09-18 | — | — | US | disclosed |
| CN-1436159-A | Processes for production of fluorinated organic compounds and fluorinating agent | DAIKIN IND LTD (JP) | 2003-08-13 | — | — | CN | disclosed |
| EP-1304316-A1 | PROCESSES FOR THE PRODUCTION OF FLUORINATED ORGANIC COMPOUNDS AND FLUORINATING AGENTS | Daikin Industries, Ltd. (JP) | 2003-04-23 | — | — | EP | disclosed |
| US-20020012155-A1 | Electrochromic materials with enhanced ultraviolet stability and devices comprising same | BAUMANN KELVIN L (US) | 2002-01-31 | — | — | US | disclosed |
| US-6195192-B1 | Electrochromic materials with enhanced ultraviolet stability | GENTEX CORPORATION | 2001-02-27 | — | — | US | disclosed |
| US-4156887-A | PYRIDINE, QUINOLINE OR 1,10-PHENANTHROLINE COMPOUND HAVING REVERSIBLE PHASE TRANSITION | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1979-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040245505-A1 | Process for the production of fluorinated organic compounds and fluorinating agents | PFAS, AFF4, AFF1 | ACHE 2172/4885BCHE 2444/4885TP53 189/4885 |
| US-20230242468-A1 | PRODUCTION METHOD FOR FLUORINATED ORGANIC COMPOUND | IPO5, PFAS, FBL | ACHE 1387/4885BCHE 1113/4885TP53 854/4885 |
| US-20030176747-A1 | Process for the production of fluorinated organic compounds and fluorinating agents | PFAS, AFF4, AFF1 | ACHE 2172/4885BCHE 2444/4885TP53 189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.